Kanagawa, Japan

Atsushi Mamiya



Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 221(Granted Patents)


Location History:

  • Kanagawa, JP (2002 - 2003)
  • Tokyo, JP (2002 - 2017)

Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Atsushi Mamiya: Innovator in Therapeutic Agents and Cell Migration Regulation

Introduction

Atsushi Mamiya is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of biomedical innovation, holding a total of 11 patents. His work focuses on developing therapeutic agents and regulators that address critical health issues.

Latest Patents

Among his latest patents, Mamiya has developed a therapeutic agent for epithelial and endothelial injury. This invention specifically targets microinjuries in these tissues and includes peptides with specific amino acid sequences. Another notable patent is a cell migration regulator that can either promote or inhibit cell migration. This regulator comprises peptides derived from blood coagulation factor IX and is designed to be used in pharmaceutical compositions.

Career Highlights

Mamiya has had a distinguished career, working with notable organizations such as Sony Corporation and Nihon University. His experience in these institutions has allowed him to refine his expertise in the development of innovative therapeutic solutions.

Collaborations

Mamiya has collaborated with several professionals in his field, including Takuya Niitsu and Shinpei Hirano. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Atsushi Mamiya's work in therapeutic agents and cell migration regulation showcases his dedication to improving health outcomes through innovation. His contributions are significant in the realm of biomedical research and continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…